Redhill Biopharma Ltd.

Redhill Biopharma Ltd. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Redhill Biopharma Ltd. is not very popular among insiders. Redhill Biopharma Ltd. is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused on the development...

News

This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate
This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate

Simply Wall St Key Insights RedHill Biopharma's Annual General Meeting to take place on 17th of September Total pay for CEO Dror...\n more…

RedHill's Talicia Advances as Preferred H. pylori Treatment
RedHill's Talicia Advances as Preferred H. pylori Treatment

TipRanks Financial Blog RedHill Biopharma (RDHL) has released an update. RedHill Biopharma Ltd. has announced that its drug Talicia® is now recommended as a first-line treatment for H. pyl...\n more…

RedHill Biopharma's Talicia listed as first-line choise for H. pylori by ACG
RedHill Biopharma's Talicia listed as first-line choise for H. pylori by ACG

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

RedHill's Talicia Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines
RedHill's Talicia Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines

PR Newswire RedHill's Talicia Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines RedHill's Talicia Listed as First-Line Choice for H. pylori in New American College...\n more…

RedHill Biopharma regains Nasdaq compliance
RedHill Biopharma regains Nasdaq compliance

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire TEL AVIV, Israel and RALEIGH...\n more…